The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $301.63

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $301.63

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Biogen Inc closed at (U.S.)$301.63.

Over the last five days, shares have lost 0.94% and are down 11.14% for the last year to date. This security has underperformed the S&P 500 by 9.87% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $301.63
  • High--
  • Low--
  • Bid / Ask(U.S.) $298.00 / (U.S.) $302.57
  • YTD % change-11.14%
  • Volume2,570
  • Average volume (10-day)2,917,547
  • Average volume (1-month)2,578,997
  • Average volume (3-month)2,377,318
  • 52-week range(U.S.) $265.00 to (U.S.) $480.18
  • Beta1.00
  • Trailing P/E20.41×
  • P/E 1 year forward18.96×
  • Forward PEG1.20×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $14.78
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+33.94%

Based on its net profit margin of 33.94%, Biogen Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue2,5922,5552,6412,511
Total other revenue--------
Total revenue2,5922,5552,6412,511
Gross profit2,3062,2432,3432,209
Total cost of revenue286312297303
Total operating expense1,3591,4371,4811,359
Selling / general / administrative492560574570
Research & development491461500417
Depreciation / amortization9296107122
Interest expense (income), net operating--------
Unusual expense (income)-283-54
Other operating expenses, total----00
Operating income1,2331,1181,1601,153
Interest income (expense), net non-operating-6-7-7-7
Gain (loss) on sale of assets--------
Other--------
Income before tax1,2221,1031,1511,136
Income after tax930821883862
Income tax, total293282268275
Net income927823883857
Total adjustments to net income--------
Net income before extra. items927823883857
Minority interest2211
Equity in affiliates-5-10-5
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items927823883857
Inc. avail. to common incl. extra. items927823883857
Diluted net income927823883857
Dilution adjustment----0--
Diluted weighted average shares236236236237
Diluted EPS excluding extraordinary itemsvalue per share3.933.493.743.62
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share3.933.523.753.44